262 related articles for article (PubMed ID: 24870785)
1. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
4. The value of hysteroscopic exploration for abnormal uterine bleeding.
Torrejon R; Fernandez-Alba JJ; Carnicer I; Martin A; Castro C; Garcia-Cabanillas J; Rodriguez-Cornejo J; Moreno LJ; Comino R
J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):453-6. PubMed ID: 9224579
[TBL] [Abstract][Full Text] [Related]
5. The process of carcinogenesis for endometrial adenocarcinoma could be short: development of a malignancy after endometrial ablation.
Ramey JW; Koonings PP; Given FT; Acosta AA
Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1370-1. PubMed ID: 8178868
[TBL] [Abstract][Full Text] [Related]
6. Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis.
Narice BF; Delaney B; Dickson JM
BMC Fam Pract; 2018 Jul; 19(1):135. PubMed ID: 30060741
[TBL] [Abstract][Full Text] [Related]
7. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
8. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.
Lee DO; Jung MH; Kim HY
J Obstet Gynaecol Res; 2011 Oct; 37(10):1423-6. PubMed ID: 21651668
[TBL] [Abstract][Full Text] [Related]
10. Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial.
Sanam M; Majid MM
Asian Pac J Cancer Prev; 2015; 16(12):4971-5. PubMed ID: 26163624
[TBL] [Abstract][Full Text] [Related]
11. Histological Pattern Of Endometrial Samples In Postmenopausal Women With Abnormal Uterine Bleeding.
Deeba F; Shaista ; Khan B
J Ayub Med Coll Abbottabad; 2016; 28(4):721-724. PubMed ID: 28586596
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of endometrial lesions in patients with abnormal uterine bleeding.
Shang M; Zhang W
Eur J Obstet Gynecol Reprod Biol; 2023 Sep; 288():67-72. PubMed ID: 37451131
[TBL] [Abstract][Full Text] [Related]
13. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
14. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
16. Is there an appropriate cutoff age for sampling the endometrium in premenopausal bleeding?
Corbacioglu Esmer A; Akbayir O; Goksedef BP; Gunduz N; Kisacık S; Dagdeviren H; Guraslan B; Ark C
Gynecol Obstet Invest; 2014; 77(1):40-4. PubMed ID: 24334971
[TBL] [Abstract][Full Text] [Related]
17. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
19. Endometrial biopsy. Finding the cause of uterine bleeding.
Mayo Clin Health Lett; 2001 Aug; 19(8):6. PubMed ID: 11475596
[No Abstract] [Full Text] [Related]
20. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
